Guichuang Tongqiao-B (02190) is now up more than 4%. As of press release, it is up 4.52% to HK$9.95, with a turnover of HK$1,819,300.
The Zhitong Finance App learned that Guichuang Tongqiao-B (02190) is now up more than 4%. As of press release, it has risen 4.52% to HK$9.95, with a turnover of HK$1.819,300.
According to the news, Guichuang Tongqiao announced that it has signed an exclusive licensing agreement and investment agreement with Avinger. Guichuang Tongqiao will receive exclusive authorization from Avinger to locally manufacture and sell a full range of products in China, Hong Kong, Macao and Taiwan regions. At the same time, Guichuang Tongqiao will become a manufacturer of Avinger products sold outside of Greater China, helping it reduce production costs and gain a competitive advantage; it will also cooperate with Avinger to sell peripheral vascular intervention products independently developed by some companies in the US and Germany.
According to the announcement, Guichuang Tongqiao will pay Avinger an investment of no more than 15 million US dollars in two installments by purchasing a combination of its newly issued common shares and preferred shares based on the achievement of business-related milestones.